Vascular cognitive impairment
…, T Erkinjuntti, B Reisberg, G Roman, T Sawada… - The Lancet …, 2003 - thelancet.com
Cerebrovascular disease is the second most common cause of acquired cognitive impairment
and dementia and contributes to cognitive decline in the neurodegenerative dementias. …
and dementia and contributes to cognitive decline in the neurodegenerative dementias. …
Enlargement of spontaneous intracerebral hemorrhage: incidence and time course
S Kazui, H Naritomi, H Yamamoto, T Sawada… - Stroke, 1996 - Am Heart Assoc
Background and Purpose Standard radiographic criteria for hematoma enlargement have not
been established. We undertook this investigation to assess the incidence and time course …
been established. We undertook this investigation to assess the incidence and time course …
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
…, M Tsushima, Y Koretsune, T Sawada… - The Lancet …, 2010 - thelancet.com
Background The antiplatelet drug cilostazol is efficacious for prevention of stroke recurrence
compared with placebo. We designed the second Cilostazol Stroke Prevention Study (…
compared with placebo. We designed the second Cilostazol Stroke Prevention Study (…
Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction
…, Y Shinohara, E Itoh, T Matsuda, T Sawada… - Journal of Stroke and …, 2000 - Elsevier
Cilostazol, an antiplatelet drug that increases the cyclic adenosine monophosphate (AMP)
levels in platelets via inhibition of cyclic AMP phosphodiesterase, has been used in chronic …
levels in platelets via inhibition of cyclic AMP phosphodiesterase, has been used in chronic …
Hemorrhagic transformation in cerebral embolism.
…, T Yamaguchi, K Minematsu, T Miyashita, T Sawada… - Stroke, 1989 - Am Heart Assoc
We studied the mechanism of hemorrhagic infarction after acute cerebral embolism in 160
patients by brain computed tomography and angiography. Hemorrhagic infarction during the …
patients by brain computed tomography and angiography. Hemorrhagic infarction during the …
Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease
…, M Maruyama, H Arai, K Yanai, T Sawada… - Journal of …, 2005 - Soc Neuroscience
Neurofibrillary tangles (NFTs), neuropil threads, and neuritic elements of senile plaques
predominantly comprise hyperphosphorylated tau protein and represent pathological …
predominantly comprise hyperphosphorylated tau protein and represent pathological …
Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke
…, T Shimizu, M Suzuki, M Ikebuchi, T Sawada… - Stroke, 1996 - Am Heart Assoc
Background and Purpose Although insulin resistance and hyperinsulinemia play a crucial
role in the pathogenesis of atherosclerosis, little is known about their roles in ischemic stroke. …
role in the pathogenesis of atherosclerosis, little is known about their roles in ischemic stroke. …
Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients.
…, Y Kuriyama, K Nagatsuka, M Nakamura, T Sawada… - …, 1994 - Am Heart Assoc
The goal of this study was to elucidate the association between the development of
periventricular white matter lucency and autoregulation of cerebral blood flow in hypertensive …
periventricular white matter lucency and autoregulation of cerebral blood flow in hypertensive …
Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease
N Hattori, K Abe, S Sakoda, T Sawada - Neuroreport, 2002 - journals.lww.com
To investigate metabolic changes in Alzheimer's disease (AD), we performed proton MR
spectroscopy at 3 T. Spectra were acquired from the gray matter of the posterior cingulate gyrus …
spectroscopy at 3 T. Spectra were acquired from the gray matter of the posterior cingulate gyrus …
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) A Randomized, Double-Blind …
Y Shinohara, K Nishimaru, T Sawada, A Terashi… - Stroke, 2008 - Am Heart Assoc
Background and Purpose— The antiplatelet agent sarpogrelate is a selective inhibitor of 5-hydroxytryptamine
receptors. The purpose of this study was to compare the efficacy and …
receptors. The purpose of this study was to compare the efficacy and …